RVNC

Revance Therapeutics (RVNC)

About Revance Therapeutics (RVNC)

Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.

Details

Daily high
$3.95
Daily low
$3.77
Price at open
$3.88
52 Week High
$9.74
52 Week Low
$2.30
Market cap
400.7M
Dividend yield
0.00%
Volume
1.2M
Avg. volume
2.1M
P/E ratio
-1.99

Revance Therapeutics News

Details

Daily high
$3.95
Daily low
$3.77
Price at open
$3.88
52 Week High
$9.74
52 Week Low
$2.30
Market cap
400.7M
Dividend yield
0.00%
Volume
1.2M
Avg. volume
2.1M
P/E ratio
-1.99